English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/154321
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Clinical relevance of biomarkers of oxidative stress

AuthorsFrijhoff, Jeroen; Cuadrado, Antonio ; Schmidt, Harald H.H.W.
Issue Date2015
PublisherMary Ann Liebert
CitationAntioxidants and Redox Signaling 23(14): 1144-1170 (2015)
Abstract[Significance]: Oxidative stress is considered to be an important component of various diseases. A vast number of methods have been developed and used in virtually all diseases to measure the extent and nature of oxidative stress, ranging from oxidation of DNA to proteins, lipids, and free amino acids. [Recent Advances]: An increased understanding of the biology behind diseases and redox biology has led to more specific and sensitive tools to measure oxidative stress markers, which are very diverse and sometimes very low in abundance. [Critical Issues]: The literature is very heterogeneous. It is often difficult to draw general conclusions on the significance of oxidative stress biomarkers, as only in a limited proportion of diseases have a range of different biomarkers been used, and different biomarkers have been used to study different diseases. In addition, biomarkers are often measured using nonspecific methods, while specific methodologies are often too sophisticated or laborious for routine clinical use. [Future Directions]: Several markers of oxidative stress still represent a viable biomarker opportunity for clinical use. However, positive findings with currently used biomarkers still need to be validated in larger sample sizes and compared with current clinical standards to establish them as clinical diagnostics. It is important to realize that oxidative stress is a nuanced phenomenon that is difficult to characterize, and one biomarker is not necessarily better than others. The vast diversity in oxidative stress between diseases and conditions has to be taken into account when selecting the most appropriate biomarker.
DescriptionThis Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License.-- et al.
Publisher version (URL)https://doi.org/10.1089/ars.2015.6317
URIhttp://hdl.handle.net/10261/154321
DOI10.1089/ars.2015.6317
Identifiersdoi: 10.1089/ars.2015.6317
e-issn: 1557-7716
issn: 1523-0864
Appears in Collections:(IIBM) Artículos
Files in This Item:
File Description SizeFormat 
biomarkestres.pdf907,55 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.